These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6156332)

  • 1. Use of first-dose response or plasma renin activity to predict the long-term effect of captopril: identification of triphasic pattern of blood pressure response.
    Case DB; Atlas SA; Laragh JH; Sullivan PA; Sealey JE
    J Cardiovasc Pharmacol; 1980; 2(4):339-46. PubMed ID: 6156332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. A serial study during pregnancy, lactation and anestrus.
    Olsson K; Fyhrquist F; Benlamlih S; Dahlborn K
    Acta Physiol Scand; 1984 May; 121(1):73-80. PubMed ID: 6377825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies (author's transl)].
    Ogihara T; Maruyama A; Mikami H; Naka T; Higaki J; Kanda T; Gotoh M; Hata T; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1185-92. PubMed ID: 396402
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance of blood pressure by the renin-angiotensin system in normal man.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Nature; 1981 May; 291(5813):329-31. PubMed ID: 7015149
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term efficacy of captopril in renovascular and essential hypertension.
    Case DB; Atlas SA; Marion RM; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
    Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.
    Laragh JH; Case DB; Atlas SA; Sealey JE
    Hypertension; 1980; 2(4):586-93. PubMed ID: 6156900
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
    Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.
    Atlas SA; Case DB; Sealey JE; Laragh JH; McKinstry DN
    Hypertension; 1979; 1(3):274-80. PubMed ID: 399239
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
    Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependency of captopril effects in severely hypertensive patients.
    Aldigier JC; Plouin PF; Alexandre JM; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1981; 3(6):1229-35. PubMed ID: 6173522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of angiotensin I converting enzyme inhibitor (captopril) on blood pressure, pulse rate, plasma renin activity, and plasma aldosterone concentration in patients with essential hypertension and normal subjects].
    Seto S; Kaku T; Shinagawa T; Matsumoto Y; Doi Y; Tasaki S; Murayama M; Aoi W; Kuramochi M; Hashiba K
    Nihon Naika Gakkai Zasshi; 1980 Nov; 69(11):1439-46. PubMed ID: 7017040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.